Letter to FDA re: Supplements marketed as women's fertility aids
CSPI writes the Food and Drug Administration (FDA) urging the agency to pursue enforcement action against dietary supplements that claim to treat female infertility.
CSPI writes the Food and Drug Administration (FDA) urging the agency to pursue enforcement action against dietary supplements that claim to treat female infertility.